Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies

• Κύριοι συγγραφείς: Olivia Wu (Συγγραφέας), Stephen Morris (Συγγραφέας), Torben Bjerregaard Larsen (Συγγραφέας), Flemming Skjøth (Συγγραφέας), Alex Evans (Συγγραφέας), Kevin Bowrin (Συγγραφέας), Piotr Wojciechowski (Συγγραφέας), Wojciech Margas (Συγγραφέας), Maria Huelsebeck (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Hindawi-Wiley, 2022-01-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background. Rivaroxaban and apixaban are the most widely used nonvitamin K oral anticoagulants (NOACs) in patients with venous thromboembolism (VTE). This meta-analysis evaluates the effectiveness and safety of both NOACs versus standard of care (SoC) in real-world practice. Methods. Real-world evid...